Explore
Validate
Learn
Western blot
Chromatin ImmunoprecipitationAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunoprecipitation [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN253029 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Chromodomain Helicase DNA Binding Protein 1 (CHD1) (AA 1660-1710) antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Epitope
- AA 1660-1710
- Vial size
- 0.1 mL
- Storage
- Store at 4°C. Do not freeze.
- Handling
- Do not freeze.
Submitted references Integrating phosphoproteomics into the clinical management of prostate cancer.
Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness.
Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer.
Treatment of breast cancer cells with DNA demethylating agents leads to a release of Pol II stalling at genes with DNA-hypermethylated regions upstream of TSS.
Lsh mediated RNA polymerase II stalling at HoxC6 and HoxC8 involves DNA methylation.
Cheng LC, Tan VM, Ganesan S, Drake JM
Clinical and translational medicine 2017 Dec;6(1):9
Clinical and translational medicine 2017 Dec;6(1):9
Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness.
Huang S, Gulzar ZG, Salari K, Lapointe J, Brooks JD, Pollack JR
Oncogene 2012 Sep 13;31(37):4164-70
Oncogene 2012 Sep 13;31(37):4164-70
Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer.
Liu W, Lindberg J, Sui G, Luo J, Egevad L, Li T, Xie C, Wan M, Kim ST, Wang Z, Turner AR, Zhang Z, Feng J, Yan Y, Sun J, Bova GS, Ewing CM, Yan G, Gielzak M, Cramer SD, Vessella RL, Zheng SL, Grönberg H, Isaacs WB, Xu J
Oncogene 2012 Aug 30;31(35):3939-48
Oncogene 2012 Aug 30;31(35):3939-48
Treatment of breast cancer cells with DNA demethylating agents leads to a release of Pol II stalling at genes with DNA-hypermethylated regions upstream of TSS.
Tao Y, Liu S, Briones V, Geiman TM, Muegge K
Nucleic acids research 2011 Dec;39(22):9508-20
Nucleic acids research 2011 Dec;39(22):9508-20
Lsh mediated RNA polymerase II stalling at HoxC6 and HoxC8 involves DNA methylation.
Tao Y, Xi S, Briones V, Muegge K
PloS one 2010 Feb 11;5(2):e9163
PloS one 2010 Feb 11;5(2):e9163
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IP
